Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up-Reference-Cited by-同舟云学术

Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up

Published:2023-02 Issue:1 Volume:2 Page:43-50
ISSN:2772-8293
Container-title:Journal of Allergy and Clinical Immunology: Global
language:en
Short-container-title:Journal of Allergy and Clinical Immunology: Global

Author:

Adlany Yasmin K.,Šošić Lara,Senti Gabriela,Lang Claudia C.V.,Wüthrich Brunello,Kündig Thomas M.,Johansen Pål

Publisher

Elsevier BV

Reference44 articles.

1. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults;Wuthrich;Int Arch Allergy Immunol,1995

2. IgE levels, atopy markers and hay fever in relation to age, sex and smoking status in a normal adult Swiss population. SAPALDIA (Swiss Study on Air Pollution and Lung Diseases in Adults) Team;Wuthrich;Int Arch Allergy Immunol,1996

3. Prevalence and rate of diagnosis of allergic rhinitis in Europe;Bauchau;Eur Respir J,2004

4. A randomised placebo-controlled trial investigating efficacy and mechanisms of low-dose intradermal allergen immunotherapy in treatment of seasonal allergic rhinitis;Slovick,2016

5. Local nasal specific immunotherapy for allergic rhinitis;Passalacqua;Allergy Asthma Clin Immunol,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluctuation of Disease Severity and Quality of Life Applying Intra-lymphatic Immunotherapy for Patients with Seasonal Allergic Rhinitis;Iranian Journal of Allergy, Asthma and Immunology;2024-04-14

2. Allergen immunotherapy: progress and future outlook;Expert Review of Clinical Immunology;2023-05-05